Three-dimensional Genome Organization Maps in Normal Haematopoietic Stem Cells and Acute Myeloid Leukemia
Wang, B.; Kong, L.; BABU, D.; Choudhary, R.; Fam, W.; Tng, J. Q.; Goh, Y.; Liu, X.; Song, F. F.; Chia, P.; Chan, M. C.; An, O.; Tham, C. Y.; Benoukraf, T.; Yang, H.; Wang, W.; Chng, W. J.; Tenen, D.; Fullwood, M. J.
Show abstract
Acute Myeloid Leukemia (AML) is a highly lethal blood cancer arising due to aberrant differentiation of haematopoietic stem cells. Here we obtained 3D genome organization maps by Hi-C in the CD34+ haematopoietic stem cells from three healthy individuals and eight individuals with AML, and found that AML have increased loops to oncogenes compared with normal CD34+ cells. The MEIS1 oncogenic transcription factor is regulated by a Frequently Interacting Region (FIRE). This FIRE is only present in normal bone marrow samples, and four of eight AML sample. FIRE presence is associated with MEIS1 expression. CRISPR excision of a FIRE boundary led to loss of MEIS1 and reduced cell growth. Moreover, MEIS1 can bind to the promoter of HOXA9, and HOXA9 shows gain of Acute Myeloid Leukemia-specific super-enhancers that loop to the HOXA9 promoter. SignificanceWe found that Acute Myeloid Leukemias have more chromatin loops to oncogenes compared with normal blood stem cells. We identified heterogeneity in chromatin interactions at oncogenes, and heterogeneity in super-enhancers that loop to oncogenes, as two key epigenetic mechanisms that underlie MEIS1 and HOXA9 oncogene expression respectively.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Functional Interrogation of HOXA9 Regulome in MLLr Leukemia via Reporter-based CRISPR/Cas9 screen 96%
- Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylation 95%
- Convergent Epigenetic Evolution Drives Relapse in Acute Myeloid Leukemia 95%
Similar papers in this journal
- Myeloid lncRNA LOUP Mediates Opposing Regulatory Effects of RUNX1 and RUNX1-ETO in t(8;21) AML 96%
- BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor 96%
- A JAK/STAT-Mediated Inflammatory Signaling Cascade Drives Oncogenesis In AF10-Rearranged AML 96%
Similar papers in this journal
- N-MYC regulates Cell Survival via eIF4G1 in inv(16) Acute Myeloid Leukemia 97%
- Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers 96%
- TCF3::HLF Orchestrates an Enhancer-Promoter Network with Activation of MEF2C to Promote Immature HSC gene Expression in Leukemia 95%
Similar papers in this journal
- Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cells 97%
- The Splicing Factor PTBP1 interacts with RUNX1 and is Required for Leukemia Cell Survival 96%
- Critical roles of Ikaros and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia 96%
Similar papers in this journal
- Adrenomedullin-CALCRL Axis Controls Relapse-Initiating Drug Tolerant Acute Myeloid Leukemia Cells 96%
- Leukemic stem cells hijack lineage inappropriate signalling pathways to promote their growth 96%
- Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.